Vimarsana
Biggest News Aggregation in the World

Page 4 - Massimo Caputi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Massimo Caputi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Massimo Caputi Today - Breaking & Trending Today

Covid Live Updates: C.D.C. Lowers Estimate of Omicron's Prevalence in U.S. - Vimarsana News

Covid Live Updates: C.D.C. Lowers Estimate of Omicron's Prevalence in U.S.

Delta, not Omicron, was the dominant variant in the United States in the week ending Dec. 18, the C.D.C. said.

Why didn't the US detect omicron cases sooner? - Vimarsana News

Why didn't the US detect omicron cases sooner?

Why didn’t the US detect omicron cases sooner?

New Recovery for Italy Tourism to the Tune of 1 Billion Euros - Vimarsana News

New Recovery for Italy Tourism to the Tune of 1 Billion Euros

Intesa Sanpaolo has made 1 billion euros available to support the recovery of small- and medium-sized enterprises in Italy tourism sector.

Florida Atlantic University researchers test for COVID-19 in saliva - Vimarsana News

Florida Atlantic University researchers test for COVID-19 in saliva

Florida Atlantic University researchers test for COVID-19 in saliva January 14, 2021 at 4:10 PM EST - Updated January 14 at 4:10 PM Researchers at Florida Atlantic University in Boca Raton are finding easier ways to test for COVID-19. The different technology is being shared with medical communities across the country. Professor Massimo Caputi said the technology behind testing for COVID-19 is changing. FAU's Charles E. Schmidt College of Medicine has found a way simpler way to test for COVID in saliva, making it quicker for labs to get results "What was taking us five hours ended up taki...

Source: wflx.com
FAU researchers develop simplified, rapid SARS-CoV-2 detection protocol - Vimarsana News

FAU researchers develop simplified, rapid SARS-CoV-2 detection protocol

FAU researchers develop simplified, rapid SARS-CoV-2 detection protocol To properly monitor and help curb the spread of COVID-19, several millions of diagnostic tests are required daily in just the United States alone. There is still a widespread lack of COVID-19 testing in the U.S. and many of the clinical diagnostics protocols require extensive human labor and materials that could face supply shortages and present biosafety concerns. The current gold standard for COVID-19 diagnostic testing in the U.S., developed by the U.S. Centers for Disease Control and Prevention (CDC), is quantitative ...